Gene · 5205
Papers1,828
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 1,828
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Emergence and Evolutionary Response of Vibrio cholerae to Novel Bacteriophage, Democratic Republic of the Congo1. | Emerg Infect Dis | 2022 | 36417939 | PubTator, text mining | PubMed |
| ARL11 correlates with the immunosuppression and poor prognosis in breast cancer: A comprehensive bioinformatics analysis of ARL family members. | PLoS One | 2022 | 36367890 | PubTator, text mining | PubMed |
| The Etiology of Cholelithiasis in Children and Adolescents-A Literature Review. | Int J Mol Sci | 2022 | 36362164 | PubTator, text mining | PubMed |
| Inferring bona fide Differentially Expressed Genes and Their Variants Associated with Vitamin K Deficiency Using a Systems Genetics Approach. | Genes (Basel) | 2022 | 36360315 | PubTator, text mining | PubMed |
| Combination of Immune-Related Network and Molecular Typing Analysis Defines a Three-Gene Signature for Predicting Prognosis of Triple-Negative Breast Cancer. | Biomolecules | 2022 | 36358906 | PubTator, text mining | PubMed |
| A novel pathogenesis concept of biliary atresia approached by combined molecular strategies. | PLoS One | 2022 | 36350824 | PubTator, text mining | PubMed |
| Pan-cancer landscape of aberrant DNA Methylation across childhood Cancers: Molecular Characteristics and Clinical relevance. | Exp Hematol Oncol | 2022 | 36348462 | PubTator, text mining | PubMed |
| Correction: Acinar ATP8b1/LPC pathway promotes macrophage efferocytosis and clearance of inflammation during chronic pancreatitis development. | Cell Death Dis | 2022 | 36344486 | PubTator, text mining | PubMed |
| Case Report: A rare case of young adult progressive familial intrahepatic cholestasis-type 3 with a novel heterozygous pathogenic variant of ABCB4. | Front Pediatr | 2022 | 36330364 | PubTator, text mining | PubMed |
| GMMchi: gene expression clustering using Gaussian mixture modeling. | BMC Bioinformatics | 2022 | 36324085 | PubTator, text mining | PubMed |
| The maximum entropy principle for compositional data. | BMC Bioinformatics | 2022 | 36309638 | PubTator, text mining | PubMed |
| ATP8B1 Deficiency Results in Elevated Mitochondrial Phosphatidylethanolamine Levels and Increased Mitochondrial Oxidative Phosphorylation in Human Hepatoma Cells. | Int J Mol Sci | 2022 | 36293199 | PubTator, text mining | PubMed |
| Protocols of Investigation of Neonatal Cholestasis-A Critical Appraisal. | Healthcare (Basel) | 2022 | 36292464 | PubTator, text mining | PubMed |
| Activation of Nrf2 to Optimise Immune Responses to Intracerebral Haemorrhage. | Biomolecules | 2022 | 36291647 | PubTator, text mining | PubMed |
| Odevixibat: a promising new treatment for progressive familial intrahepatic cholestasis. | Expert Opin Pharmacother | 2022 | 36278881 | PubTator, text mining | PubMed |
| A BCB4 variant is associated with hepatobiliary MR abnormalities in people with low-phospholipid-associated cholelithiasis syndrome. | JHEP Rep | 2022 | 36277956 | PubTator, text mining | PubMed |
| Druggable targets and therapeutic development for COVID-19. | Front Chem | 2022 | 36277347 | PubTator, text mining | PubMed |
| A pyroptosis-associated gene risk model for predicting the prognosis of triple-negative breast cancer. | Front Oncol | 2022 | 36276158 | PubTator, text mining | PubMed |
| Acinar ATP8b1/LPC pathway promotes macrophage efferocytosis and clearance of inflammation during chronic pancreatitis development. | Cell Death Dis | 2022 | 36273194 | PubTator, text mining | PubMed |
| KLF7 promotes preadipocyte proliferation via activation of the Akt signaling pathway by Cis-regulating CDKN3. | Acta Biochim Biophys Sin (Shanghai) | 2022 | 36269137 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5205/papers?page=17